Biolinq Company

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information. Under the leadership of Jared Tangney and Josh Windmiller, Biolinq is redefining how biomedical innovations can be imagined and commercialized. While conducting his post-doctoral research at the University of California, San Diego in the laboratory for NanoBioElectronics, Josh saw the potential to bring nanotechnology to the medical world. Combining forces with Jared, a Ph.D. in Biomedical Engineering, the two saw the opportunity to bring their minimally-invasive technology to the diabetes space. Finally, people with diabetes will have a better CGM experience that is not only more affordable but also pain-free.
Technology: AgeTech - Medical Devices
Industry: mHealth
Headquarters: San Diego
Founded Date: 2012-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 22
Total Funding: $196,251,237
Estimated Revenue: $1M to $10M
Last Funding Date: 2020
Last Funding Type: Venture - Series Unknown

Visit Website
careers@biolinq.me
Register and Claim Ownership